| Dr Nabeel A Khan, MD | |
|
3950 Austell Rd, Austell, GA 30106-1121 | |
| (770) 732-4000 | |
| Not Available |
| Full Name | Dr Nabeel A Khan |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 30 Years |
| Location | 3950 Austell Rd, Austell, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811003213 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 056847 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Emory Decatur Hospital | Decatur, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Emory Specialty Associates, Llc | 3476559782 | 430 |
News Archive
Ninety-five percent of older African-American clinic patients reported at least some exposure to racism during their lives in a study by researchers at the San Francisco VA Medical Center and the University of California, San Francisco.
Arguments in the two cases, which are the first two challenges to the Obama administration's health overhaul to advance from the federal to appellate level, mark the beginning in what some say is a race to the Supreme Court.
Amerigroup Corporation today announced that net income for the fourth quarter of 2009 was $40.2 million, or $0.79 per diluted share, versus $35.9 million, or $0.67 per diluted share, for the fourth quarter of 2008. For the year ended December 31, 2009, the Company's net income was $149.3 million, or $2.85 per diluted share.
GeoVax Labs, Inc., announced today the expansion of the Phase 2a clinical trial testing of its HIV/AIDS vaccine products. The expanded Phase 2a trial will test the administration of three doses of the recombinant poxvirus vaccine MVA62B without the use of the recombinant DNA-vectored vaccine, which was used to prime immune responses in the first part of this trial.
In an invited presentation today before the annual meeting of the American Academy of Neurology, Knopp Neurosciences Inc. described further encouraging trends observed in a previously reported Phase 2 study of KNS-760704 (dexpramipexole) in ALS.
› Verified 6 days ago
| Entity Name | Georgia Anesthesiologists, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740299197 PECOS PAC ID: 7315835063 Enrollment ID: O20040305000398 |
News Archive
Ninety-five percent of older African-American clinic patients reported at least some exposure to racism during their lives in a study by researchers at the San Francisco VA Medical Center and the University of California, San Francisco.
Arguments in the two cases, which are the first two challenges to the Obama administration's health overhaul to advance from the federal to appellate level, mark the beginning in what some say is a race to the Supreme Court.
Amerigroup Corporation today announced that net income for the fourth quarter of 2009 was $40.2 million, or $0.79 per diluted share, versus $35.9 million, or $0.67 per diluted share, for the fourth quarter of 2008. For the year ended December 31, 2009, the Company's net income was $149.3 million, or $2.85 per diluted share.
GeoVax Labs, Inc., announced today the expansion of the Phase 2a clinical trial testing of its HIV/AIDS vaccine products. The expanded Phase 2a trial will test the administration of three doses of the recombinant poxvirus vaccine MVA62B without the use of the recombinant DNA-vectored vaccine, which was used to prime immune responses in the first part of this trial.
In an invited presentation today before the annual meeting of the American Academy of Neurology, Knopp Neurosciences Inc. described further encouraging trends observed in a previously reported Phase 2 study of KNS-760704 (dexpramipexole) in ALS.
› Verified 6 days ago
| Entity Name | Emory Specialty Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407864168 PECOS PAC ID: 3476559782 Enrollment ID: O20061010000447 |
News Archive
Ninety-five percent of older African-American clinic patients reported at least some exposure to racism during their lives in a study by researchers at the San Francisco VA Medical Center and the University of California, San Francisco.
Arguments in the two cases, which are the first two challenges to the Obama administration's health overhaul to advance from the federal to appellate level, mark the beginning in what some say is a race to the Supreme Court.
Amerigroup Corporation today announced that net income for the fourth quarter of 2009 was $40.2 million, or $0.79 per diluted share, versus $35.9 million, or $0.67 per diluted share, for the fourth quarter of 2008. For the year ended December 31, 2009, the Company's net income was $149.3 million, or $2.85 per diluted share.
GeoVax Labs, Inc., announced today the expansion of the Phase 2a clinical trial testing of its HIV/AIDS vaccine products. The expanded Phase 2a trial will test the administration of three doses of the recombinant poxvirus vaccine MVA62B without the use of the recombinant DNA-vectored vaccine, which was used to prime immune responses in the first part of this trial.
In an invited presentation today before the annual meeting of the American Academy of Neurology, Knopp Neurosciences Inc. described further encouraging trends observed in a previously reported Phase 2 study of KNS-760704 (dexpramipexole) in ALS.
› Verified 6 days ago
| Entity Name | Concordia Anesthesiology Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619296464 PECOS PAC ID: 8325172885 Enrollment ID: O20100819000220 |
News Archive
Ninety-five percent of older African-American clinic patients reported at least some exposure to racism during their lives in a study by researchers at the San Francisco VA Medical Center and the University of California, San Francisco.
Arguments in the two cases, which are the first two challenges to the Obama administration's health overhaul to advance from the federal to appellate level, mark the beginning in what some say is a race to the Supreme Court.
Amerigroup Corporation today announced that net income for the fourth quarter of 2009 was $40.2 million, or $0.79 per diluted share, versus $35.9 million, or $0.67 per diluted share, for the fourth quarter of 2008. For the year ended December 31, 2009, the Company's net income was $149.3 million, or $2.85 per diluted share.
GeoVax Labs, Inc., announced today the expansion of the Phase 2a clinical trial testing of its HIV/AIDS vaccine products. The expanded Phase 2a trial will test the administration of three doses of the recombinant poxvirus vaccine MVA62B without the use of the recombinant DNA-vectored vaccine, which was used to prime immune responses in the first part of this trial.
In an invited presentation today before the annual meeting of the American Academy of Neurology, Knopp Neurosciences Inc. described further encouraging trends observed in a previously reported Phase 2 study of KNS-760704 (dexpramipexole) in ALS.
› Verified 6 days ago
| Entity Name | Wellstar Medical Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558664003 PECOS PAC ID: 6709065402 Enrollment ID: O20110127000374 |
News Archive
Ninety-five percent of older African-American clinic patients reported at least some exposure to racism during their lives in a study by researchers at the San Francisco VA Medical Center and the University of California, San Francisco.
Arguments in the two cases, which are the first two challenges to the Obama administration's health overhaul to advance from the federal to appellate level, mark the beginning in what some say is a race to the Supreme Court.
Amerigroup Corporation today announced that net income for the fourth quarter of 2009 was $40.2 million, or $0.79 per diluted share, versus $35.9 million, or $0.67 per diluted share, for the fourth quarter of 2008. For the year ended December 31, 2009, the Company's net income was $149.3 million, or $2.85 per diluted share.
GeoVax Labs, Inc., announced today the expansion of the Phase 2a clinical trial testing of its HIV/AIDS vaccine products. The expanded Phase 2a trial will test the administration of three doses of the recombinant poxvirus vaccine MVA62B without the use of the recombinant DNA-vectored vaccine, which was used to prime immune responses in the first part of this trial.
In an invited presentation today before the annual meeting of the American Academy of Neurology, Knopp Neurosciences Inc. described further encouraging trends observed in a previously reported Phase 2 study of KNS-760704 (dexpramipexole) in ALS.
› Verified 6 days ago
| Entity Name | Mak Anesthesia Cobb Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699045070 PECOS PAC ID: 7810154960 Enrollment ID: O20120201000868 |
News Archive
Ninety-five percent of older African-American clinic patients reported at least some exposure to racism during their lives in a study by researchers at the San Francisco VA Medical Center and the University of California, San Francisco.
Arguments in the two cases, which are the first two challenges to the Obama administration's health overhaul to advance from the federal to appellate level, mark the beginning in what some say is a race to the Supreme Court.
Amerigroup Corporation today announced that net income for the fourth quarter of 2009 was $40.2 million, or $0.79 per diluted share, versus $35.9 million, or $0.67 per diluted share, for the fourth quarter of 2008. For the year ended December 31, 2009, the Company's net income was $149.3 million, or $2.85 per diluted share.
GeoVax Labs, Inc., announced today the expansion of the Phase 2a clinical trial testing of its HIV/AIDS vaccine products. The expanded Phase 2a trial will test the administration of three doses of the recombinant poxvirus vaccine MVA62B without the use of the recombinant DNA-vectored vaccine, which was used to prime immune responses in the first part of this trial.
In an invited presentation today before the annual meeting of the American Academy of Neurology, Knopp Neurosciences Inc. described further encouraging trends observed in a previously reported Phase 2 study of KNS-760704 (dexpramipexole) in ALS.
› Verified 6 days ago
| Entity Name | Mak Anesthesia Holdings, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912452939 PECOS PAC ID: 4284917204 Enrollment ID: O20170216001563 |
News Archive
Ninety-five percent of older African-American clinic patients reported at least some exposure to racism during their lives in a study by researchers at the San Francisco VA Medical Center and the University of California, San Francisco.
Arguments in the two cases, which are the first two challenges to the Obama administration's health overhaul to advance from the federal to appellate level, mark the beginning in what some say is a race to the Supreme Court.
Amerigroup Corporation today announced that net income for the fourth quarter of 2009 was $40.2 million, or $0.79 per diluted share, versus $35.9 million, or $0.67 per diluted share, for the fourth quarter of 2008. For the year ended December 31, 2009, the Company's net income was $149.3 million, or $2.85 per diluted share.
GeoVax Labs, Inc., announced today the expansion of the Phase 2a clinical trial testing of its HIV/AIDS vaccine products. The expanded Phase 2a trial will test the administration of three doses of the recombinant poxvirus vaccine MVA62B without the use of the recombinant DNA-vectored vaccine, which was used to prime immune responses in the first part of this trial.
In an invited presentation today before the annual meeting of the American Academy of Neurology, Knopp Neurosciences Inc. described further encouraging trends observed in a previously reported Phase 2 study of KNS-760704 (dexpramipexole) in ALS.
› Verified 6 days ago
| Entity Name | Mak Anesthesia Northside Affiliates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609390103 PECOS PAC ID: 7315203718 Enrollment ID: O20171116002499 |
News Archive
Ninety-five percent of older African-American clinic patients reported at least some exposure to racism during their lives in a study by researchers at the San Francisco VA Medical Center and the University of California, San Francisco.
Arguments in the two cases, which are the first two challenges to the Obama administration's health overhaul to advance from the federal to appellate level, mark the beginning in what some say is a race to the Supreme Court.
Amerigroup Corporation today announced that net income for the fourth quarter of 2009 was $40.2 million, or $0.79 per diluted share, versus $35.9 million, or $0.67 per diluted share, for the fourth quarter of 2008. For the year ended December 31, 2009, the Company's net income was $149.3 million, or $2.85 per diluted share.
GeoVax Labs, Inc., announced today the expansion of the Phase 2a clinical trial testing of its HIV/AIDS vaccine products. The expanded Phase 2a trial will test the administration of three doses of the recombinant poxvirus vaccine MVA62B without the use of the recombinant DNA-vectored vaccine, which was used to prime immune responses in the first part of this trial.
In an invited presentation today before the annual meeting of the American Academy of Neurology, Knopp Neurosciences Inc. described further encouraging trends observed in a previously reported Phase 2 study of KNS-760704 (dexpramipexole) in ALS.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nabeel A Khan, MD 607 Concord Lake Ln Se, Smyrna, GA 30082-2634 Ph: (678) 333-4477 | Dr Nabeel A Khan, MD 3950 Austell Rd, Austell, GA 30106-1121 Ph: (770) 732-4000 |
News Archive
Ninety-five percent of older African-American clinic patients reported at least some exposure to racism during their lives in a study by researchers at the San Francisco VA Medical Center and the University of California, San Francisco.
Arguments in the two cases, which are the first two challenges to the Obama administration's health overhaul to advance from the federal to appellate level, mark the beginning in what some say is a race to the Supreme Court.
Amerigroup Corporation today announced that net income for the fourth quarter of 2009 was $40.2 million, or $0.79 per diluted share, versus $35.9 million, or $0.67 per diluted share, for the fourth quarter of 2008. For the year ended December 31, 2009, the Company's net income was $149.3 million, or $2.85 per diluted share.
GeoVax Labs, Inc., announced today the expansion of the Phase 2a clinical trial testing of its HIV/AIDS vaccine products. The expanded Phase 2a trial will test the administration of three doses of the recombinant poxvirus vaccine MVA62B without the use of the recombinant DNA-vectored vaccine, which was used to prime immune responses in the first part of this trial.
In an invited presentation today before the annual meeting of the American Academy of Neurology, Knopp Neurosciences Inc. described further encouraging trends observed in a previously reported Phase 2 study of KNS-760704 (dexpramipexole) in ALS.
› Verified 6 days ago
David A Reeder, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3950 Austell Road, Austell, GA 30106 Phone: 770-732-3649 Fax: 770-732-3648 | |
Robert Silverman, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3950 Austell Rd, Austell, GA 30106 Phone: 770-732-3649 Fax: 773-732-3648 | |
Thakorbhai Patel, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 3950 Austell Rd, Austell, GA 30106 Phone: 770-732-3649 Fax: 770-732-3648 | |
David Termotto, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 3950 Austell Rd, Austell, GA 30106 Phone: 770-732-3649 Fax: 770-732-3648 | |
Anne Vidanagama, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 3950 Austell Road, Austell, GA 30106 Phone: 770-732-3649 Fax: 770-732-3648 | |
Kamela Coleman, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3950 Austell Rd, Austell, GA 30106 Phone: 770-732-3649 Fax: 770-732-3648 | |
Mr. Ajay Handa, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3950 Austell Road, Austell, GA 30106 Phone: 770-732-3649 Fax: 770-732-3648 |